Martin Adrian P, Bartels Michael, Kiehle Adrien, Hauss Johann, Fangmann Josef
Universitatsklinikum Leipzig, Abteilung fur Viszeral-, Transplantations-, Thorax- und Gefasschirurgie, Liebigstrasse 20, 04103 Leipzig, Germany.
Transpl Int. 2008 Mar;21(3):263-7. doi: 10.1111/j.1432-2277.2007.00601.x. Epub 2007 Dec 19.
The aim of the study is to evaluate the changes in kidney function after pre-emptive kidney transplantation in patients with polycystic liver and kidney disease (PLKD) and to establish whether pre-emptive kidney transplantation is warranted. Between 1998 and 2006, five patients with severe anatomical changes in both native kidneys but only mild alteration of the clearance function received combined liver and kidney transplantation. Preoperatively, Technetium-99m mercaptoacetyltriglycine (Tc99m MAG3) scintigraphy was used to evaluate separately the function of each native kidney. This examination was repeated six months after transplantation, additionally measuring the function of the transplanted kidney. Pretransplant creatinine levels were 77-115 mumol/l and Tc99m MAG3 clearance was 141-163 ml/min/1.73 sqm (74 +/- 8% of minimum-for-age values). Six months after transplant, creatinine values were not significantly different. Minimum-for-age clearance decreased by 12.5 +/- 11.5% in four patients, and increased by 26% in one patient. In four patients, the transplanted and the native kidneys assumed each about one third of total tracer clearance. In one patient, the transplanted kidney assumed 92% of the clearance function. Kidney function decreases despite pre-emptive kidney transplantation. Native kidneys are not functionally excluded and the clearance seems to be divided between native and transplanted organs. Kidney transplantation in nonuremic PLKD patients does not improve the overall kidney function and should be performed only in exceptional cases.
本研究的目的是评估多囊肝肾病(PLKD)患者进行抢先肾移植后肾功能的变化,并确定抢先肾移植是否必要。1998年至2006年间,5例双侧原肾有严重解剖学改变但清除功能仅有轻度改变的患者接受了肝肾联合移植。术前,使用锝-99m巯基乙酰三甘氨酸(Tc99m MAG3)闪烁扫描分别评估每个原肾的功能。移植后6个月重复此项检查,同时测量移植肾的功能。移植前肌酐水平为77 - 115μmol/L,Tc99m MAG3清除率为141 - 163 ml/min/1.73 m²(为年龄相关最小值的74±8%)。移植后6个月,肌酐值无显著差异。4例患者年龄相关最小清除率下降了12.5±11.5%,1例患者上升了26%。4例患者中,移植肾和原肾各承担约三分之一的总示踪剂清除率。1例患者中,移植肾承担了92%的清除功能。尽管进行了抢先肾移植,肾功能仍会下降。原肾在功能上未被排除,清除功能似乎在原肾和移植肾之间分配。非尿毒症PLKD患者进行肾移植并不能改善整体肾功能,仅在特殊情况下才可进行。